CHICAGO—The outgoing president of ASCO, Dr Michael Link from Stanford University School of Medicine in California, answers questions from Peter Goodwin about the progress achieved in cancer clinical s
Michael Link
CHICAGO—The outgoing president of ASCO, Dr Michael Link from Stanford University School of Medicine in California, answers questions from Peter Goodwin about the progress achieved in cancer clinical science during his year in office. He talks specifically about new research on using involved field radiation in patients with high-risk Hodgkin’s Lymphoma, and about three of the key presentations given at the ASCO Plenary Session:
– Emtansine: a new immuno-conjugate is proof of principle and a new option for HER2 positive metastatic breast cancer
– A new tyrosine kinase inhibitor, regorafenib, is a life giving option for patients with imatinib resistant GIST
– A drug developed in the old East Germany, bendamustine, was found to be more effective and less toxic than CHOP in patients with indolent lymphomas.
LISTEN
[audio:https://www.audiomedica.com/podcasting/news/120616MichaelLinkLoResPODCAST.mp3]
Related Episodes
Jefferson DeKloe BSc: Big US Study Confirms Benefit of HPV Vaccination for Boys as Well as Girls
The cancer prevention benefit of vaccination against the human papilloma virus cancer prevent are slowly accruing thanks to European, American and other population-based studies. I’m Peter Goodwin wi
Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025
Luis G Paz-Ares MD PhD discdusses the addition of lurbinectedin as maintenance therapy for extensive stage small cell lung cancer (SCLC)
Frank A Sinicrope MD: Stage 3 Colon Cancer with Deficient Mismatch Repair: Big Gains from Atezolizumab Added to Standard Chemotherapy
An interview with: Frank A Sinicrope, MD, Medical Oncologist, Mayo Clinic, Rochester, Minnesota. CHICAGO —Big gains in survival have been reported among patients with stage three, node-positive colon